Fingolimod Recruiting Phase 4 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03345940Fingolimod Versus Dimethyl-fumarate in Multiple Sclerosis